Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Low-cost generic programs offer CVD meds at affordable prices | Strain imaging making a significant impact

News You Need to Know Today
Low-cost generic programs offer CVD meds at affordable prices | Strain imaging making a significant impact
Friday, September 15, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Low-cost generic programs offer CVD medications at affordable prices—but availability changes from one to the next

Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Low-cost generic programs offer CVD medications at affordable prices—but availability changes from one to the next

Share on Twitter Share on Facebook Share on Linkedin
Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. 
READ MORE >

Strain imaging making a significant impact on the treatment of heart patients

Strain imaging has gained considerable momentum in recent years as an effective tool for getting more value out of heart evaluations. Ritu Thamman, MD, provided an in-depth look at the latest trends in strain echocardiography in an exclusive interview. 

READ MORE >
Ritu Thamman, MD, FASE, University of Pittsburgh School of Medicine, discusses trends and the technical aspects of strain imaging. #ASE #ASE23 #ASE2023 #strainecho
Share on Twitter Share on Facebook Share on Linkedin

Strain imaging making a significant impact on the treatment of heart patients

Share on Twitter Share on Facebook Share on Linkedin
Ritu Thamman, MD, FASE, University of Pittsburgh School of Medicine, discusses trends and the technical aspects of strain imaging. #ASE #ASE23 #ASE2023 #strainecho
Strain imaging has gained considerable momentum in recent years as an effective tool for getting more value out of heart evaluations. Ritu Thamman, MD, provided an in-depth look at the latest trends in strain echocardiography in an exclusive interview. 
READ MORE >

Featured Articles

Understanding reimbursements and coding for echocardiography

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 

READ MORE >
Video of Denise Garris, ASE regulatory consultant and principal of the Korris Group, explaining how reimbursements from insurance andMedicare work to pay or cardiac ultrasound exams. #ASE #ASE360 #ASE23 #ASE2023 #healthcarereimbursment
Share on Twitter Share on Facebook Share on Linkedin

Understanding reimbursements and coding for echocardiography

Share on Twitter Share on Facebook Share on Linkedin
Video of Denise Garris, ASE regulatory consultant and principal of the Korris Group, explaining how reimbursements from insurance andMedicare work to pay or cardiac ultrasound exams. #ASE #ASE360 #ASE23 #ASE2023 #healthcarereimbursment
"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 
READ MORE >

Private equity-backed cardiology management group expands Florida footprint again with latest acquisition

Orlando-based Cardiovascular Associates of America has now acquired six Florida practices in 2023 alone. This most recent deal includes a team of 13 cardiologists who operate out of six locations. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology management group expands Florida footprint again with latest acquisition

Share on Twitter Share on Facebook Share on Linkedin
Orlando-based Cardiovascular Associates of America has now acquired six Florida practices in 2023 alone. This most recent deal includes a team of 13 cardiologists who operate out of six locations. 
READ MORE >

Another long-term benefit of AFib ablation: Improved mental health

A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.

READ MORE >
cardiologist preparing to perform radiofrequency ablation
Share on Twitter Share on Facebook Share on Linkedin

Another long-term benefit of AFib ablation: Improved mental health

Share on Twitter Share on Facebook Share on Linkedin
cardiologist preparing to perform radiofrequency ablation
A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.
READ MORE >

In Case You Missed It

Key takeaways from ESC Congress 2023

Steen Dalby Kristensen, a cardiologist with Aarhus University Hospital in Denmark, detailed some of the hottest topics at the European Society of Cardiology's annual meeting. 

READ MORE >
VIDEO of Prof. Steen Kristensen explaining key trials and news from ESC 2023. #ESC #ESCcongress #ESC2023 ESCcongress2023
Share on Twitter Share on Facebook Share on Linkedin

Key takeaways from ESC Congress 2023

Share on Twitter Share on Facebook Share on Linkedin
VIDEO of Prof. Steen Kristensen explaining key trials and news from ESC 2023. #ESC #ESCcongress #ESC2023 ESCcongress2023
Steen Dalby Kristensen, a cardiologist with Aarhus University Hospital in Denmark, detailed some of the hottest topics at the European Society of Cardiology's annual meeting. 
READ MORE >

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists. 

READ MORE >
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

Share on Twitter Share on Facebook Share on Linkedin
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists. 
READ MORE >

In Other News

FDA announces recall of Abbott neurostimulation devices after MRI-related issues lead to 73 injuries

The new recall, which includes more than 155,000 implantable pulse generators, is due to ongoing issues with the devices being unable to exit MRI mode and return to normal use. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of Abbott neurostimulation devices after MRI-related issues lead to 73 injuries

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The new recall, which includes more than 155,000 implantable pulse generators, is due to ongoing issues with the devices being unable to exit MRI mode and return to normal use. 
READ MORE >

FDA clears new MRI-compatible robot for breast biopsies

The newly cleared device from Insight Medbotics represents a collaboration between robotics experts and surgeons. 

READ MORE >
The IGAR surgical robot. Image courtesy of Insight Medbotics.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new MRI-compatible robot for breast biopsies

Share on Twitter Share on Facebook Share on Linkedin
The IGAR surgical robot. Image courtesy of Insight Medbotics.
The newly cleared device from Insight Medbotics represents a collaboration between robotics experts and surgeons. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup